On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

During his time in Columbus, Dr. Miller published an illustrated book, “Principles of Health Preservation”, which observed ...

Patient demographics and basic clinical data were analyzed ... CHB, central nervous system hemangioblastoma; RA, retinal hemangioblastoma; RCC, renal cell carcinoma; PHEO, pheochromocytoma; PCL/PNET, ...

Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Anita Osborn outlines the best ways to start and maintain a patient support initiative in an increasingly complex health environment. As the healthcare environment continues to evolve, patient ...

A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in ...

Objectives Primary sclerosing cholangitis (PSC) is a rare chronic disease that presents challenges to both patients and ...

Industry giants like Takeda Pharmaceuticals, Pfizer, Novartis, and Bayer are revolutionizing treatment landscapes, paving the way for enhanced patien ...

On this World Cancer Day, Chris Vogelsang, a cancer survivor from upstate New York, is celebrating his recovery thanks to a ...